Soft tissue amyloid neoplasm

Summary

Soft tissue amyloid neoplasm (MONDO:0024892) is a cancer. A subtype of soft tissue neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	soft tissue amyloid neoplasm
Mondo ID	MONDO:0024892
DOID	DOID:6755
NCIT	C8323
GARD	0025473
Is cancer (heuristic)	yes

Also known as: amyloid tumor (morphologic abnormality) · amyloid tumour · amyloid tumour (morphologic abnormality) · soft tissue amyloid neoplasm · soft tissue amyloid tumor · soft tissue amyloid tumour

Disease family

This is a subtype of soft tissue neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › connective and soft tissue neoplasm › soft tissue neoplasm › soft tissue amyloid neoplasm

Related subtypes (17): synovium neoplasm, central nervous system mesenchymal non-meningothelial tumor, mediastinal mesenchymal tumor, nodular fasciitis, mixed endometrial stromal and smooth muscle tumor, neoplasm with perivascular epithelioid cell differentiation, desmoid tumor, congenital epulis, inflammatory myofibroblastic tumor, juvenile hyaline fibromatosis, kaposiform hemangioendothelioma, glomus tumor, Mazabraud syndrome, melanoma of soft tissue, malignant soft tissue neoplasm, fibromyxoid tumor, benign soft tissue neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.